These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 15659801)

  • 21. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.
    Lampiasi N; Azzolina A; D'Alessandro N; Umezawa K; McCubrey JA; Montalto G; Cervello M
    Mol Pharmacol; 2009 Aug; 76(2):290-300. PubMed ID: 19461054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody.
    Yue L; Wang Y; Wang H; Gao H; Liang J; Sui A; Xiang J; Zhou F; Xu C; Zhao W; Liang W; Yao R
    Oncol Rep; 2012 Oct; 28(4):1453-60. PubMed ID: 22895605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor II regulation of gene expression in rat and human hepatomas.
    Zvibel I; Brill S; Reid LM
    J Cell Physiol; 1995 Jan; 162(1):36-43. PubMed ID: 7529237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II.
    Kuo WW; Liu CJ; Chen LM; Wu CH; Chu CH; Liu JY; Lu MC; Lin JA; Lee SD; Huang CY
    Apoptosis; 2006 Jul; 11(7):1075-89. PubMed ID: 16699953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoid protects hepatoma cells against metabolic stress-induced cell death.
    Uen YH; Ko PH; Yin PH; Liu TY; Chi CW; Lui WY
    Int J Oncol; 2008 Dec; 33(6):1263-70. PubMed ID: 19020760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of insulin, insulin-like growth factor-I and -II on proliferation and intracellular signaling in endometrial carcinoma cells with different expression levels of insulin receptor isoform A.
    Wang CF; Zhang G; Zhao LJ; Li XP; Qi WJ; Wang JL; Wei LH
    Chin Med J (Engl); 2013; 126(8):1560-6. PubMed ID: 23595395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor I (IGF-I) stimulates proliferation but also increases caspase-3 activity, Annexin-V binding, and DNA-fragmentation in human MG63 osteosarcoma cells: co-activation of pro- and anti-apoptotic pathways by IGF-I.
    Raile K; Hille R; Laue S; Schulz A; Pfeifer G; Horn F; Kiess W
    Horm Metab Res; 2003; 35(11-12):786-93. PubMed ID: 14710359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leptin, insulin-like growth factor-1, and insulin-like growth factor-2 are mitogens in ApcMin/+ but not Apc+/+ colonic epithelial cell lines.
    Fenton JI; Hord NG; Lavigne JA; Perkins SN; Hursting SD
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1646-52. PubMed ID: 16030096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor I stimulates proliferation and Fas-mediated apoptosis of human osteoblasts.
    Kawakami A; Nakashima T; Tsuboi M; Urayama S; Matsuoka N; Ida H; Kawabe Y; Sakai H; Migita K; Aoyagi T; Nakashima M; Maeda K; Eguchi K
    Biochem Biophys Res Commun; 1998 Jun; 247(1):46-51. PubMed ID: 9636651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis.
    Foulstone EJ; Meadows KA; Holly JM; Stewart CE
    J Cell Physiol; 2001 Nov; 189(2):207-15. PubMed ID: 11598906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.
    Shimizu M; Shirakami Y; Sakai H; Tatebe H; Nakagawa T; Hara Y; Weinstein IB; Moriwaki H
    Cancer Lett; 2008 Apr; 262(1):10-8. PubMed ID: 18164805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt.
    Yeh J; Litz J; Hauck P; Ludwig DL; Krystal GW
    Lung Cancer; 2008 May; 60(2):166-74. PubMed ID: 18006183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
    Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
    Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNAi-mediated silencing of insulin receptor substrate-4 enhances actinomycin D- and tumor necrosis factor-alpha-induced cell death in hepatocarcinoma cancer cell lines.
    Cuevas EP; Escribano O; Monserrat J; Martínez-Botas J; Sánchez MG; Chiloeches A; Hernández-Breijo B; Sánchez-Alonso V; Román ID; Fernández-Moreno MD; Guijarro LG
    J Cell Biochem; 2009 Dec; 108(6):1292-301. PubMed ID: 19795387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells.
    van der Burg B; Isbrücker L; van Selm-Miltenburg AJ; de Laat SW; van Zoelen EJ
    Cancer Res; 1990 Dec; 50(24):7770-4. PubMed ID: 2174732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.
    Kim KW; Bae SK; Lee OH; Bae MH; Lee MJ; Park BC
    Cancer Res; 1998 Jan; 58(2):348-51. PubMed ID: 9443416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis.
    Huynh H; Nguyen TT; Chow KH; Tan PH; Soo KC; Tran E
    BMC Gastroenterol; 2003 Aug; 3():19. PubMed ID: 12906713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
    Nishimura D; Ishikawa H; Matsumoto K; Shibata H; Motoyoshi Y; Fukuta M; Kawashimo H; Goto T; Taura N; Ichikawa T; Hamasaki K; Nakao K; Umezawa K; Eguchi K
    Int J Oncol; 2006 Sep; 29(3):713-9. PubMed ID: 16865289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.